Impact of policosanol combined with atorvastatin on high-density lipoprotein subfractions
Author:
Affiliation:

Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease,Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing 100037, China)

Clc Number:

R542. 2

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Aim To investigate the impact of policosanol combined with atorvastatin on high-density lipoprotein subfractions. Methods A total of 49 consecutively patients with hyperlipidemia were assigned to receive placebo (control group, n=17), atorvastatin 20 mg (n=16) or policosanol 20mg combined with atorvastatin 20 mg (n=16). The baseline clinical characteristics were collected and the HDL lipoprint system was used for lipid subfraction quantification. Results After 8 weeks’ treatment, the reduction of triglyceride (TG), total cholesterol (TC) and low-density lipoprotein cholesterol (LDLC) was significant in both atorvastatin group and policosanol combined with atorvastatin group (P<0.05 or P<0.001, respectively), while the change of high-density lipoprotein cholesterol (HDLC) level had no significant difference (P>0.05). Both in groups of atorvastatin and policosanol combined with atorvastatin, large HDLC subfraction level and large HDLC subfraction percentage significantly increased after treatment (all for P<0.05), while small HDLC subfraction level and small HDLC subfraction percentage markedly reduced. Further analysis showed that the reduction of small HDLC subfraction level and small HDLC subfraction percentage was more marked (P<0.05 for atorvastatin group and P<0.001 for policosanol combined with atorvastatin, respectively) in policosanol combined with atorvastatin group compared to atorvastatin group. Conclusion After treatment with atorvastatin or policosanol combined with atorvastatin, the distribution of HDL subfractions was significantly improved by an increase of large HDL subfraction and a reduction of small HDL subfraction. The reduction of small HDLC subfraction level and percentage was more marked in policosanol combined with atorvastatin group than that in atorvastatin group.

    Reference
    Related
    Cited by
Get Citation

XU Rui-Xia, GUO Yuan-Lin, LI Sha, ZHANG Yan, LI Xiao-Lin, YAO Yu-Hong, MA Chun-Yan, LIU Geng, DONG Qian, SUN Jing, LI Jian-Jun. Impact of policosanol combined with atorvastatin on high-density lipoprotein subfractions[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2017,25(2):149-152.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 31,2016
  • Revised:October 26,2016
  • Online: February 08,2017
Article QR Code